2021 CSBrS实践指南:超声引导下真空辅助乳腺活检

2021-06-07 乳腺外科学会 乳腺外科学会

乳房纤维腺瘤是妇女最常见的良性肿瘤,可发生在所有年龄段,常见于15-35岁的女性。

乳房纤维腺瘤是妇女最常见的良性肿瘤,可发生在所有年龄段,常见于15-35岁的女性。

大多数乳腺纤维腺瘤往往是自我限制性生长,通常在几年后稳定下来。临床诊断主要是基于临床触诊和超声检查。诊断主要基于临床触诊和超声检查,而金标准病理检查是诊断的黄金标准。

为了规范乳腺纤维腺瘤的临床诊断和治疗。中华医学会乳腺外科分会(CSBrS)对专家意见进行了文献综述,并确定了文献综述和专家意见,并确定了乳腺纤维腺瘤临床实践指南的关键临床问题。以制定乳腺纤维腺瘤的临床实践指南。

课题组采用建议分级法评估了相关证据,并制定了乳腺纤维腺瘤临床实践指南。

CSBrS实践指南2021,其目的是为为中国的乳腺外科医生提供临床实践指导。

详情参见:2021 CSBrS实践指南:超声引导下真空辅助乳腺活检(需要中文翻译的,请在下方评论哦,超过20个求翻译评论,我们将对此篇进行翻译哦~)

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2184808, encodeId=689c2184808c6, content=求翻译, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9909162676, createdName=ms9000001454640832, createdTime=Tue Jan 30 13:24:40 CST 2024, time=2024-01-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1813485, encodeId=25571813485b7, content=<a href='/topic/show?id=0ba692e7473' target=_blank style='color:#2F92EE;'>#超声引#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92774, encryptionId=0ba692e7473, topicName=超声引)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb182500058, createdName=yuhaisheng_ibp_32061711, createdTime=Mon May 09 20:28:19 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2031839, encodeId=2da12031839d6, content=<a href='/topic/show?id=5df2460e269' target=_blank style='color:#2F92EE;'>#实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46072, encryptionId=5df2460e269, topicName=实践指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Thu May 12 11:28:19 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003536, encodeId=3a54100353629, content=求翻译, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97141619787, createdName=Mayo, createdTime=Thu Jul 29 10:15:21 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1769834, encodeId=5e421e69834f5, content=<a href='/topic/show?id=b3fc92e7516' target=_blank style='color:#2F92EE;'>#超声引导#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92775, encryptionId=b3fc92e7516, topicName=超声引导)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d66e38113145, createdName=guoyibin, createdTime=Wed Nov 03 17:28:19 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1278232, encodeId=28bd12e823250, content=<a href='/topic/show?id=d34e6523544' target=_blank style='color:#2F92EE;'>#活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65235, encryptionId=d34e6523544, topicName=活检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Wed Jun 09 02:28:19 CST 2021, time=2021-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493625, encodeId=3a7714936250c, content=<a href='/topic/show?id=aa2923e177d' target=_blank style='color:#2F92EE;'>#乳腺活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23717, encryptionId=aa2923e177d, topicName=乳腺活检)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acba9077826, createdName=circumcision, createdTime=Wed Jun 09 02:28:19 CST 2021, time=2021-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971635, encodeId=c3f19e1635dd, content=乳房纤维腺瘤是妇女最常见的良性肿瘤,可发生在所有年龄段,值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd984965877, createdName=1453df99m58暂无昵称, createdTime=Mon Jun 07 21:45:57 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971485, encodeId=c49b9e148503, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er2icISIlFBOOS0O4UuL65GeGuiaYU2bHQUE0QIfxanf4k9COMcrBxPXILGN1zln7NcvDDicEqR5UMqg/132, createdBy=68162475471, createdName=ms6169241532840991, createdTime=Mon Jun 07 11:44:26 CST 2021, time=2021-06-07, status=1, ipAttribution=)]
    2024-01-30 ms9000001454640832 来自上海

    求翻译

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2184808, encodeId=689c2184808c6, content=求翻译, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9909162676, createdName=ms9000001454640832, createdTime=Tue Jan 30 13:24:40 CST 2024, time=2024-01-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1813485, encodeId=25571813485b7, content=<a href='/topic/show?id=0ba692e7473' target=_blank style='color:#2F92EE;'>#超声引#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92774, encryptionId=0ba692e7473, topicName=超声引)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb182500058, createdName=yuhaisheng_ibp_32061711, createdTime=Mon May 09 20:28:19 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2031839, encodeId=2da12031839d6, content=<a href='/topic/show?id=5df2460e269' target=_blank style='color:#2F92EE;'>#实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46072, encryptionId=5df2460e269, topicName=实践指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Thu May 12 11:28:19 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003536, encodeId=3a54100353629, content=求翻译, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97141619787, createdName=Mayo, createdTime=Thu Jul 29 10:15:21 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1769834, encodeId=5e421e69834f5, content=<a href='/topic/show?id=b3fc92e7516' target=_blank style='color:#2F92EE;'>#超声引导#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92775, encryptionId=b3fc92e7516, topicName=超声引导)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d66e38113145, createdName=guoyibin, createdTime=Wed Nov 03 17:28:19 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1278232, encodeId=28bd12e823250, content=<a href='/topic/show?id=d34e6523544' target=_blank style='color:#2F92EE;'>#活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65235, encryptionId=d34e6523544, topicName=活检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Wed Jun 09 02:28:19 CST 2021, time=2021-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493625, encodeId=3a7714936250c, content=<a href='/topic/show?id=aa2923e177d' target=_blank style='color:#2F92EE;'>#乳腺活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23717, encryptionId=aa2923e177d, topicName=乳腺活检)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acba9077826, createdName=circumcision, createdTime=Wed Jun 09 02:28:19 CST 2021, time=2021-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971635, encodeId=c3f19e1635dd, content=乳房纤维腺瘤是妇女最常见的良性肿瘤,可发生在所有年龄段,值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd984965877, createdName=1453df99m58暂无昵称, createdTime=Mon Jun 07 21:45:57 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971485, encodeId=c49b9e148503, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er2icISIlFBOOS0O4UuL65GeGuiaYU2bHQUE0QIfxanf4k9COMcrBxPXILGN1zln7NcvDDicEqR5UMqg/132, createdBy=68162475471, createdName=ms6169241532840991, createdTime=Mon Jun 07 11:44:26 CST 2021, time=2021-06-07, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2184808, encodeId=689c2184808c6, content=求翻译, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9909162676, createdName=ms9000001454640832, createdTime=Tue Jan 30 13:24:40 CST 2024, time=2024-01-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1813485, encodeId=25571813485b7, content=<a href='/topic/show?id=0ba692e7473' target=_blank style='color:#2F92EE;'>#超声引#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92774, encryptionId=0ba692e7473, topicName=超声引)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb182500058, createdName=yuhaisheng_ibp_32061711, createdTime=Mon May 09 20:28:19 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2031839, encodeId=2da12031839d6, content=<a href='/topic/show?id=5df2460e269' target=_blank style='color:#2F92EE;'>#实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46072, encryptionId=5df2460e269, topicName=实践指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Thu May 12 11:28:19 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003536, encodeId=3a54100353629, content=求翻译, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97141619787, createdName=Mayo, createdTime=Thu Jul 29 10:15:21 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1769834, encodeId=5e421e69834f5, content=<a href='/topic/show?id=b3fc92e7516' target=_blank style='color:#2F92EE;'>#超声引导#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92775, encryptionId=b3fc92e7516, topicName=超声引导)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d66e38113145, createdName=guoyibin, createdTime=Wed Nov 03 17:28:19 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1278232, encodeId=28bd12e823250, content=<a href='/topic/show?id=d34e6523544' target=_blank style='color:#2F92EE;'>#活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65235, encryptionId=d34e6523544, topicName=活检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Wed Jun 09 02:28:19 CST 2021, time=2021-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493625, encodeId=3a7714936250c, content=<a href='/topic/show?id=aa2923e177d' target=_blank style='color:#2F92EE;'>#乳腺活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23717, encryptionId=aa2923e177d, topicName=乳腺活检)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acba9077826, createdName=circumcision, createdTime=Wed Jun 09 02:28:19 CST 2021, time=2021-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971635, encodeId=c3f19e1635dd, content=乳房纤维腺瘤是妇女最常见的良性肿瘤,可发生在所有年龄段,值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd984965877, createdName=1453df99m58暂无昵称, createdTime=Mon Jun 07 21:45:57 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971485, encodeId=c49b9e148503, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er2icISIlFBOOS0O4UuL65GeGuiaYU2bHQUE0QIfxanf4k9COMcrBxPXILGN1zln7NcvDDicEqR5UMqg/132, createdBy=68162475471, createdName=ms6169241532840991, createdTime=Mon Jun 07 11:44:26 CST 2021, time=2021-06-07, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2184808, encodeId=689c2184808c6, content=求翻译, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9909162676, createdName=ms9000001454640832, createdTime=Tue Jan 30 13:24:40 CST 2024, time=2024-01-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1813485, encodeId=25571813485b7, content=<a href='/topic/show?id=0ba692e7473' target=_blank style='color:#2F92EE;'>#超声引#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92774, encryptionId=0ba692e7473, topicName=超声引)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb182500058, createdName=yuhaisheng_ibp_32061711, createdTime=Mon May 09 20:28:19 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2031839, encodeId=2da12031839d6, content=<a href='/topic/show?id=5df2460e269' target=_blank style='color:#2F92EE;'>#实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46072, encryptionId=5df2460e269, topicName=实践指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Thu May 12 11:28:19 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003536, encodeId=3a54100353629, content=求翻译, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97141619787, createdName=Mayo, createdTime=Thu Jul 29 10:15:21 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1769834, encodeId=5e421e69834f5, content=<a href='/topic/show?id=b3fc92e7516' target=_blank style='color:#2F92EE;'>#超声引导#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92775, encryptionId=b3fc92e7516, topicName=超声引导)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d66e38113145, createdName=guoyibin, createdTime=Wed Nov 03 17:28:19 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1278232, encodeId=28bd12e823250, content=<a href='/topic/show?id=d34e6523544' target=_blank style='color:#2F92EE;'>#活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65235, encryptionId=d34e6523544, topicName=活检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Wed Jun 09 02:28:19 CST 2021, time=2021-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493625, encodeId=3a7714936250c, content=<a href='/topic/show?id=aa2923e177d' target=_blank style='color:#2F92EE;'>#乳腺活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23717, encryptionId=aa2923e177d, topicName=乳腺活检)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acba9077826, createdName=circumcision, createdTime=Wed Jun 09 02:28:19 CST 2021, time=2021-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971635, encodeId=c3f19e1635dd, content=乳房纤维腺瘤是妇女最常见的良性肿瘤,可发生在所有年龄段,值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd984965877, createdName=1453df99m58暂无昵称, createdTime=Mon Jun 07 21:45:57 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971485, encodeId=c49b9e148503, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er2icISIlFBOOS0O4UuL65GeGuiaYU2bHQUE0QIfxanf4k9COMcrBxPXILGN1zln7NcvDDicEqR5UMqg/132, createdBy=68162475471, createdName=ms6169241532840991, createdTime=Mon Jun 07 11:44:26 CST 2021, time=2021-06-07, status=1, ipAttribution=)]
    2021-07-29 Mayo

    求翻译

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2184808, encodeId=689c2184808c6, content=求翻译, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9909162676, createdName=ms9000001454640832, createdTime=Tue Jan 30 13:24:40 CST 2024, time=2024-01-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1813485, encodeId=25571813485b7, content=<a href='/topic/show?id=0ba692e7473' target=_blank style='color:#2F92EE;'>#超声引#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92774, encryptionId=0ba692e7473, topicName=超声引)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb182500058, createdName=yuhaisheng_ibp_32061711, createdTime=Mon May 09 20:28:19 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2031839, encodeId=2da12031839d6, content=<a href='/topic/show?id=5df2460e269' target=_blank style='color:#2F92EE;'>#实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46072, encryptionId=5df2460e269, topicName=实践指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Thu May 12 11:28:19 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003536, encodeId=3a54100353629, content=求翻译, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97141619787, createdName=Mayo, createdTime=Thu Jul 29 10:15:21 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1769834, encodeId=5e421e69834f5, content=<a href='/topic/show?id=b3fc92e7516' target=_blank style='color:#2F92EE;'>#超声引导#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92775, encryptionId=b3fc92e7516, topicName=超声引导)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d66e38113145, createdName=guoyibin, createdTime=Wed Nov 03 17:28:19 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1278232, encodeId=28bd12e823250, content=<a href='/topic/show?id=d34e6523544' target=_blank style='color:#2F92EE;'>#活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65235, encryptionId=d34e6523544, topicName=活检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Wed Jun 09 02:28:19 CST 2021, time=2021-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493625, encodeId=3a7714936250c, content=<a href='/topic/show?id=aa2923e177d' target=_blank style='color:#2F92EE;'>#乳腺活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23717, encryptionId=aa2923e177d, topicName=乳腺活检)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acba9077826, createdName=circumcision, createdTime=Wed Jun 09 02:28:19 CST 2021, time=2021-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971635, encodeId=c3f19e1635dd, content=乳房纤维腺瘤是妇女最常见的良性肿瘤,可发生在所有年龄段,值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd984965877, createdName=1453df99m58暂无昵称, createdTime=Mon Jun 07 21:45:57 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971485, encodeId=c49b9e148503, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er2icISIlFBOOS0O4UuL65GeGuiaYU2bHQUE0QIfxanf4k9COMcrBxPXILGN1zln7NcvDDicEqR5UMqg/132, createdBy=68162475471, createdName=ms6169241532840991, createdTime=Mon Jun 07 11:44:26 CST 2021, time=2021-06-07, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2184808, encodeId=689c2184808c6, content=求翻译, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9909162676, createdName=ms9000001454640832, createdTime=Tue Jan 30 13:24:40 CST 2024, time=2024-01-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1813485, encodeId=25571813485b7, content=<a href='/topic/show?id=0ba692e7473' target=_blank style='color:#2F92EE;'>#超声引#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92774, encryptionId=0ba692e7473, topicName=超声引)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb182500058, createdName=yuhaisheng_ibp_32061711, createdTime=Mon May 09 20:28:19 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2031839, encodeId=2da12031839d6, content=<a href='/topic/show?id=5df2460e269' target=_blank style='color:#2F92EE;'>#实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46072, encryptionId=5df2460e269, topicName=实践指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Thu May 12 11:28:19 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003536, encodeId=3a54100353629, content=求翻译, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97141619787, createdName=Mayo, createdTime=Thu Jul 29 10:15:21 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1769834, encodeId=5e421e69834f5, content=<a href='/topic/show?id=b3fc92e7516' target=_blank style='color:#2F92EE;'>#超声引导#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92775, encryptionId=b3fc92e7516, topicName=超声引导)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d66e38113145, createdName=guoyibin, createdTime=Wed Nov 03 17:28:19 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1278232, encodeId=28bd12e823250, content=<a href='/topic/show?id=d34e6523544' target=_blank style='color:#2F92EE;'>#活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65235, encryptionId=d34e6523544, topicName=活检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Wed Jun 09 02:28:19 CST 2021, time=2021-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493625, encodeId=3a7714936250c, content=<a href='/topic/show?id=aa2923e177d' target=_blank style='color:#2F92EE;'>#乳腺活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23717, encryptionId=aa2923e177d, topicName=乳腺活检)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acba9077826, createdName=circumcision, createdTime=Wed Jun 09 02:28:19 CST 2021, time=2021-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971635, encodeId=c3f19e1635dd, content=乳房纤维腺瘤是妇女最常见的良性肿瘤,可发生在所有年龄段,值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd984965877, createdName=1453df99m58暂无昵称, createdTime=Mon Jun 07 21:45:57 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971485, encodeId=c49b9e148503, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er2icISIlFBOOS0O4UuL65GeGuiaYU2bHQUE0QIfxanf4k9COMcrBxPXILGN1zln7NcvDDicEqR5UMqg/132, createdBy=68162475471, createdName=ms6169241532840991, createdTime=Mon Jun 07 11:44:26 CST 2021, time=2021-06-07, status=1, ipAttribution=)]
    2021-06-09 smlt2008
  7. [GetPortalCommentsPageByObjectIdResponse(id=2184808, encodeId=689c2184808c6, content=求翻译, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9909162676, createdName=ms9000001454640832, createdTime=Tue Jan 30 13:24:40 CST 2024, time=2024-01-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1813485, encodeId=25571813485b7, content=<a href='/topic/show?id=0ba692e7473' target=_blank style='color:#2F92EE;'>#超声引#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92774, encryptionId=0ba692e7473, topicName=超声引)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb182500058, createdName=yuhaisheng_ibp_32061711, createdTime=Mon May 09 20:28:19 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2031839, encodeId=2da12031839d6, content=<a href='/topic/show?id=5df2460e269' target=_blank style='color:#2F92EE;'>#实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46072, encryptionId=5df2460e269, topicName=实践指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Thu May 12 11:28:19 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003536, encodeId=3a54100353629, content=求翻译, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97141619787, createdName=Mayo, createdTime=Thu Jul 29 10:15:21 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1769834, encodeId=5e421e69834f5, content=<a href='/topic/show?id=b3fc92e7516' target=_blank style='color:#2F92EE;'>#超声引导#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92775, encryptionId=b3fc92e7516, topicName=超声引导)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d66e38113145, createdName=guoyibin, createdTime=Wed Nov 03 17:28:19 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1278232, encodeId=28bd12e823250, content=<a href='/topic/show?id=d34e6523544' target=_blank style='color:#2F92EE;'>#活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65235, encryptionId=d34e6523544, topicName=活检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Wed Jun 09 02:28:19 CST 2021, time=2021-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493625, encodeId=3a7714936250c, content=<a href='/topic/show?id=aa2923e177d' target=_blank style='color:#2F92EE;'>#乳腺活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23717, encryptionId=aa2923e177d, topicName=乳腺活检)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acba9077826, createdName=circumcision, createdTime=Wed Jun 09 02:28:19 CST 2021, time=2021-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971635, encodeId=c3f19e1635dd, content=乳房纤维腺瘤是妇女最常见的良性肿瘤,可发生在所有年龄段,值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd984965877, createdName=1453df99m58暂无昵称, createdTime=Mon Jun 07 21:45:57 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971485, encodeId=c49b9e148503, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er2icISIlFBOOS0O4UuL65GeGuiaYU2bHQUE0QIfxanf4k9COMcrBxPXILGN1zln7NcvDDicEqR5UMqg/132, createdBy=68162475471, createdName=ms6169241532840991, createdTime=Mon Jun 07 11:44:26 CST 2021, time=2021-06-07, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=2184808, encodeId=689c2184808c6, content=求翻译, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9909162676, createdName=ms9000001454640832, createdTime=Tue Jan 30 13:24:40 CST 2024, time=2024-01-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1813485, encodeId=25571813485b7, content=<a href='/topic/show?id=0ba692e7473' target=_blank style='color:#2F92EE;'>#超声引#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92774, encryptionId=0ba692e7473, topicName=超声引)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb182500058, createdName=yuhaisheng_ibp_32061711, createdTime=Mon May 09 20:28:19 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2031839, encodeId=2da12031839d6, content=<a href='/topic/show?id=5df2460e269' target=_blank style='color:#2F92EE;'>#实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46072, encryptionId=5df2460e269, topicName=实践指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Thu May 12 11:28:19 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003536, encodeId=3a54100353629, content=求翻译, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97141619787, createdName=Mayo, createdTime=Thu Jul 29 10:15:21 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1769834, encodeId=5e421e69834f5, content=<a href='/topic/show?id=b3fc92e7516' target=_blank style='color:#2F92EE;'>#超声引导#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92775, encryptionId=b3fc92e7516, topicName=超声引导)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d66e38113145, createdName=guoyibin, createdTime=Wed Nov 03 17:28:19 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1278232, encodeId=28bd12e823250, content=<a href='/topic/show?id=d34e6523544' target=_blank style='color:#2F92EE;'>#活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65235, encryptionId=d34e6523544, topicName=活检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Wed Jun 09 02:28:19 CST 2021, time=2021-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493625, encodeId=3a7714936250c, content=<a href='/topic/show?id=aa2923e177d' target=_blank style='color:#2F92EE;'>#乳腺活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23717, encryptionId=aa2923e177d, topicName=乳腺活检)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acba9077826, createdName=circumcision, createdTime=Wed Jun 09 02:28:19 CST 2021, time=2021-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971635, encodeId=c3f19e1635dd, content=乳房纤维腺瘤是妇女最常见的良性肿瘤,可发生在所有年龄段,值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd984965877, createdName=1453df99m58暂无昵称, createdTime=Mon Jun 07 21:45:57 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971485, encodeId=c49b9e148503, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er2icISIlFBOOS0O4UuL65GeGuiaYU2bHQUE0QIfxanf4k9COMcrBxPXILGN1zln7NcvDDicEqR5UMqg/132, createdBy=68162475471, createdName=ms6169241532840991, createdTime=Mon Jun 07 11:44:26 CST 2021, time=2021-06-07, status=1, ipAttribution=)]
    2021-06-07 1453df99m58暂无昵称

    乳房纤维腺瘤是妇女最常见的良性肿瘤,可发生在所有年龄段,值得关注

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2184808, encodeId=689c2184808c6, content=求翻译, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9909162676, createdName=ms9000001454640832, createdTime=Tue Jan 30 13:24:40 CST 2024, time=2024-01-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1813485, encodeId=25571813485b7, content=<a href='/topic/show?id=0ba692e7473' target=_blank style='color:#2F92EE;'>#超声引#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92774, encryptionId=0ba692e7473, topicName=超声引)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb182500058, createdName=yuhaisheng_ibp_32061711, createdTime=Mon May 09 20:28:19 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2031839, encodeId=2da12031839d6, content=<a href='/topic/show?id=5df2460e269' target=_blank style='color:#2F92EE;'>#实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46072, encryptionId=5df2460e269, topicName=实践指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Thu May 12 11:28:19 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003536, encodeId=3a54100353629, content=求翻译, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97141619787, createdName=Mayo, createdTime=Thu Jul 29 10:15:21 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1769834, encodeId=5e421e69834f5, content=<a href='/topic/show?id=b3fc92e7516' target=_blank style='color:#2F92EE;'>#超声引导#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92775, encryptionId=b3fc92e7516, topicName=超声引导)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d66e38113145, createdName=guoyibin, createdTime=Wed Nov 03 17:28:19 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1278232, encodeId=28bd12e823250, content=<a href='/topic/show?id=d34e6523544' target=_blank style='color:#2F92EE;'>#活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65235, encryptionId=d34e6523544, topicName=活检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Wed Jun 09 02:28:19 CST 2021, time=2021-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493625, encodeId=3a7714936250c, content=<a href='/topic/show?id=aa2923e177d' target=_blank style='color:#2F92EE;'>#乳腺活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23717, encryptionId=aa2923e177d, topicName=乳腺活检)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acba9077826, createdName=circumcision, createdTime=Wed Jun 09 02:28:19 CST 2021, time=2021-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971635, encodeId=c3f19e1635dd, content=乳房纤维腺瘤是妇女最常见的良性肿瘤,可发生在所有年龄段,值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd984965877, createdName=1453df99m58暂无昵称, createdTime=Mon Jun 07 21:45:57 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971485, encodeId=c49b9e148503, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er2icISIlFBOOS0O4UuL65GeGuiaYU2bHQUE0QIfxanf4k9COMcrBxPXILGN1zln7NcvDDicEqR5UMqg/132, createdBy=68162475471, createdName=ms6169241532840991, createdTime=Mon Jun 07 11:44:26 CST 2021, time=2021-06-07, status=1, ipAttribution=)]
    2021-06-07 ms6169241532840991

    学习了

    0

相关资讯

超声引导下真空辅助乳腺活检手术专家共识及操作指南(2017版)

中华医学会外科学分会乳腺外科学组组织国内部分专家在多次讨论的基础上,特制定本共识和手术操作指南。 本共识主要针对超声引导下VABB 对乳腺可疑病灶活检及良性病灶切除手术。不包括X 线摄影和MRI 引导下VABB 乳腺病灶手术。

拓展阅读

超声引导下真空辅助乳腺活检手术专家共识及操作指南(2017版)

中华医学会外科学分会乳腺外科学组组织国内部分专家在多次讨论的基础上,特制定本共识和手术操作指南。 本共识主要针对超声引导下VABB 对乳腺可疑病灶活检及良性病灶切除手术。不包括X 线摄影和MRI 引导下VABB 乳腺病灶手术。